BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,143 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $18,398 | -21.7% | 550 | 0.0% | 0.00% | -33.3% |
Q1 2024 | $23,507 | -10.6% | 550 | -19.1% | 0.00% | 0.0% |
Q4 2023 | $26,289 | +2.4% | 680 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $25,663 | -17.2% | 680 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $30,981 | +12.3% | 680 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $27,581 | +68852.5% | 680 | -12.8% | 0.00% | -20.0% |
Q4 2022 | $40 | -99.9% | 780 | 0.0% | 0.01% | -16.7% |
Q3 2022 | $42,000 | -17.6% | 780 | -2.0% | 0.01% | -14.3% |
Q2 2022 | $51,000 | -17.7% | 796 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $62,000 | -12.7% | 796 | -2.7% | 0.01% | 0.0% |
Q4 2021 | $71,000 | +7.6% | 818 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $66,000 | 0.0% | 818 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $66,000 | -4.3% | 818 | 0.0% | 0.01% | -12.5% |
Q1 2021 | $69,000 | -1.4% | 818 | -6.8% | 0.01% | 0.0% |
Q4 2020 | $70,000 | -1.4% | 878 | 0.0% | 0.01% | -11.1% |
Q3 2020 | $71,000 | -12.3% | 878 | -6.4% | 0.01% | -18.2% |
Q2 2020 | $81,000 | +6.6% | 938 | 0.0% | 0.01% | -15.4% |
Q1 2020 | $76,000 | -5.0% | 938 | -2.3% | 0.01% | +30.0% |
Q4 2019 | $80,000 | -4.8% | 960 | 0.0% | 0.01% | -9.1% |
Q3 2019 | $84,000 | +7.7% | 960 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $78,000 | +39.3% | 960 | +40.1% | 0.01% | +37.5% |
Q1 2019 | $56,000 | +16.7% | 685 | -5.5% | 0.01% | 0.0% |
Q4 2018 | $48,000 | -52.5% | 725 | -44.2% | 0.01% | -42.9% |
Q3 2018 | $101,000 | +5.2% | 1,300 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $96,000 | +10.3% | 1,300 | -1.9% | 0.01% | +7.7% |
Q1 2018 | $87,000 | +2.4% | 1,325 | 0.0% | 0.01% | +8.3% |
Q4 2017 | $85,000 | +2.4% | 1,325 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $83,000 | -8.8% | 1,325 | -11.8% | 0.01% | -7.7% |
Q2 2017 | $91,000 | +16.7% | 1,503 | 0.0% | 0.01% | +8.3% |
Q1 2017 | $78,000 | +18.2% | 1,503 | 0.0% | 0.01% | +20.0% |
Q4 2016 | $66,000 | -88.1% | 1,503 | -80.0% | 0.01% | -87.0% |
Q1 2014 | $554,000 | +5.7% | 7,530 | 0.0% | 0.08% | +5.5% |
Q4 2013 | $524,000 | -14.5% | 7,530 | -19.3% | 0.07% | -22.3% |
Q3 2013 | $613,000 | -5.4% | 9,330 | -0.3% | 0.09% | +14.6% |
Q2 2013 | $648,000 | – | 9,355 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |